UBS Upgrades Gap Stock to Buy, Price Target Hits $41
UBS raises Gap stock rating to Buy with $41 price target, citing improved sales outlook, beauty and handbag expansion, and Athleta growth potential.
UBS raises Gap stock rating to Buy with $41 price target, citing improved sales outlook, beauty and handbag expansion, and Athleta growth potential.
President Trump proposes 50% increase in US military spending to $1.5 trillion by 2027, citing tariff revenue as funding source despite budget concerns.
Applied Digital (APLD) reports Q2 2026 earnings that exceed analyst estimates, driven by AI data center expansion and major hyperscaler partnerships.
AbbVie denies reports of buying Revolution Medicines after Wall Street Journal claimed advanced talks.
German consumer goods giant Henkel AG submits offer to acquire Olaplex Holdings, the haircare brand that lost over 90% of its value since 2021 IPO.
Defense stocks fall as Trump prohibits dividends and buybacks, caps executive pay at $5M, demanding contractors invest in equipment instead.